4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
about
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.
P2860
4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
4-(trans-4-Methylcyclohexyl)-4 ...... w class of antidiabetic agent.
@en
type
label
4-(trans-4-Methylcyclohexyl)-4 ...... w class of antidiabetic agent.
@en
prefLabel
4-(trans-4-Methylcyclohexyl)-4 ...... w class of antidiabetic agent.
@en
P2093
P356
P1476
4-(trans-4-Methylcyclohexyl)-4 ...... ew class of antidiabetic agent
@en
P2093
P304
P356
10.1021/JM9804228
P407
P50
P577
1998-12-01T00:00:00Z